Compare GLP-1 Providers

Every head-to-head comparison we publish, grouped by provider. Each one works from the same checks: what you actually pay per month once the intro period ends, which medication you get, whether the dose is included, and how hard it is to cancel.

Last updated August 8, 2026. Some links are affiliate links — see our advertising disclosure.

MEDVi comparisons

Every head-to-head we publish featuring MEDVi.

MEDVi vs FoundMEDVi vs Found compared. May 2026 pricing, 12-month cost math, insurance rules, cancellation gotchas, FDA context, and the right pick for you.
MEDVi vs GalaMEDVi vs Gala GLP-1 compared: verified pricing, FDA warning letter context, BBB & Trustpilot data, cancellation rules, and who should choose each in 2026.
MEDVi vs Henry MedsMEDVi starts at $179/mo, Henry Meds at $297. We verified pricing, cancel policies & trust signals for both. See which fits your budget — takes 4 minutes.
MEDVi vs HersMEDVi ($179 month 1, $299/mo after) vs Hers (membership + medication path). Verified pricing, reviews, and cancel rules — updated March 30, 2026.
MEDVi vs HimsMEDVi: $179/mo, no contract, cancel anytime. Hims: $199/mo but $1,194 upfront. One lets you walk away — the other doesn't. Full 2026 breakdown.
MEDVi vs Ivim HealthMEDVi vs Ivim Health: who wins on cost, who wins on flexibility, both providers’ FDA status — and who should skip both. Verified April 2026.
MEDVi vs Lilly DirectMedVi vs LillyDirect compared: 12-month pricing at every dose, safety profiles, refill rules, cancellation policies, real reviews, and who each is best
MEDVi vs Mystart GLP-1MedVi or MyStart? We compared real pricing after month one, support, cancellation rules, and safety so you can pick the right GLP-1 program fast
MEDVi vs NoomMEDVi vs Noom Med — what's actually cheaper after month 1, what's included, and who should pick which? Verified 2026 pricing, real results and downsides.
MEDVi vs OzempicMEDVi vs Ozempic: program vs FDA-approved drug. MEDVi $179 intro/$299 refills; Ozempic $199 intro then $349–$499/mo cash-pay. Verified April 2026.
MEDVi vs PiperMEDVi vs Piper — we compared the real month-1 and year-1 cost, clinical oversight, pharmacy sourcing, support quality, and cancellation policies. See
MEDVi vs Remedy MedsCompare MEDVi vs Remedy Meds: verified pricing, cancellation rules, and FDA context. MEDVi from $179/mo, Remedy Meds $299/mo.
MEDVi vs RoMEDVi ($179-$299/mo) vs Ro ($149/mo + meds) compared: real costs, patient reviews, safety, and decision framework.
MEDVi vs Sesame CareMEDVi vs Sesame Care 2026: real all-in costs, FDA warning letter context, Costco math, and a clear verdict on which GLP-1 program fits your situation.
MEDVi vs SproutMEDVi vs Sprout Health: verified pricing, Trustpilot reviews, FDA warnings, cancellation policies, and 12-month cost math for 2026.
MEDVi vs TrimRxMEDVi or TrimRx — which GLP-1 plan actually delivers? We checked real checkout prices, 11,498 Trustpilot reviews, FDA warnings & cancel policies so you
MEDVi vs WegovyMEDVi vs Wegovy in 2026: $179 first month vs $25 insured or $149 cash. Compare costs, FDA status, and best-fit path.
MEDVi vs WillowMEDVi vs Willow compared: real pricing, oral vs injection options, cancellation rules, state availability, and trust flags — so you can choose fast.
MEDVi vs Yucca HealthMEDVi ($179, no contract) vs Yucca ($146/mo, 6-month plan). Real cost math, refund gotchas, and honest verdict.
MEDVi vs ZepboundMEDVi or Zepbound? See real costs by dose, the LillyDirect refill trap most sites won't mention, and a 60-second decision rule. (Feb 2026)

Eden comparisons

Every head-to-head we publish featuring Eden.

SHED comparisons

Every head-to-head we publish featuring SHED.

TrimRx comparisons

Every head-to-head we publish featuring TrimRx.

Ro comparisons

Every head-to-head we publish featuring Ro.

Embody comparisons

Every head-to-head we publish featuring Embody.

Medication & format comparisons

Drug-versus-drug and compounded-versus-brand breakdowns, independent of provider.

More provider comparisons

Additional head-to-head matchups across the rest of the market.